Genalyte Announces Oversubscribed $50 Million Financing Round to Expand Testing Menu and Deploy Platform
Diagnostic and Analytics Company Aims to Revolutionize Laboratory Testing and Analytics Genalyte, a leading diagnostics, and analytics company, announced today the closure of $50 million in financing. Genalyte’s Maverick™ Diagnostic System (MDS) uses silicon chip...
Genalyte Obtains FDA Emergency Use Authorization for Rapid COVID-19 Antibody Test
Instrument-Based, Rapid Test Uses Multi-Antigen Approach; Achieves Best-in-Class Sensitivity and Specificity Genalyte, a leading point-of-care diagnostics and analytics company, announced today its SARS-CoV-2 Multi-Antigen Serology Panel has received Emergency Use...
Genalyte Appoints Ashraf Hanna, M.D., Ph.D., as Chief Executive Officer
Genalyte, a leading point of care diagnostics and analytics company, announced today the appointment of Ashraf Hanna, M.D. Ph.D, as CEO. “The selection of Dr. Hanna as CEO reflects Genalyte’s transition to the next phase of the company’s development and growth. The...
Genalyte Expands COVID-19 Antibody Testing To Del Mar Fairgrounds
Antibody Testing Efforts Continue to Expand Throughout San Diego With New Site Opening July 15 July 15, 2020 (San Diego, CA) – San Diego-based healthcare analytics and diagnostics company, Genalyte, today announced the opening of a new COVID-19 antibody testing...
Genalyte Expands Testing Capabilities to Houston With COVID-19 Antibody Testing
Company Makes Serology Testing More Widely Available in Houston as Coronavirus Cases Continue to Surge Genalyte, the company empowering physicians and patients with real-time diagnostics and healthcare analytics, today announced its SARS-CoV-2 Multi-Antigen Serology...